---
title: "Top 10 HK Stock Losers (7.25)"
description: "CARLINK TECH(02531) fell 11.39%, with a trading turnover 16.0 Million HKD, and a year-to-date fell 52.5%. MEITU(01357) fell 10.64%, with a trading turnover 2.3 Billion HKD, and a year-to-date rose 256"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/250235241.md"
published_at: "2025-07-26T08:30:51.000Z"
---

# Top 10 HK Stock Losers (7.25)

> CARLINK TECH(02531) fell 11.39%, with a trading turnover 16.0 Million HKD, and a year-to-date fell 52.5%. MEITU(01357) fell 10.64%, with a trading turnover 2.3 Billion HKD, and a year-to-date rose 256%. EVEREST MED(01952) fell 9.74%, with a trading turnover 3.2 Billion HKD, and a year-to-date rose 44.6%.

Hang Seng Index has fell 1.09%, with a year-to-date rose 26.6%; Hang Seng TECH Index has fell 1.13%, with a year-to-date rose 27.1%.

CARLINK TECH(02531) fell 11.39%, with a trading turnover 16.0 Million HKD, and a year-to-date fell 52.5%.

MEITU(01357) fell 10.64%, with a trading turnover 2.3 Billion HKD, and a year-to-date rose 256%.

EVEREST MED(01952) fell 9.74%, with a trading turnover 3.2 Billion HKD, and a year-to-date rose 44.6%.

### Related Stocks

- [02531.HK - CARLINK TECH](https://longbridge.com/en/quote/02531.HK.md)
- [01357.HK - MEITU](https://longbridge.com/en/quote/01357.HK.md)
- [01952.HK - EVEREST MED](https://longbridge.com/en/quote/01952.HK.md)
- [00933.HK - VIVA GOODS](https://longbridge.com/en/quote/00933.HK.md)
- [06655.HK - HX BLDG MAT](https://longbridge.com/en/quote/06655.HK.md)
- [01072.HK - DONGFANG ELEC](https://longbridge.com/en/quote/01072.HK.md)
- [01276.HK - HENGRUI PHARMA](https://longbridge.com/en/quote/01276.HK.md)
- [01286.HK - IMPRO PRECISION](https://longbridge.com/en/quote/01286.HK.md)
- [01530.HK - 3SBIO](https://longbridge.com/en/quote/01530.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Angry passengers left high and dry after Star Cruises cancels Hong Kong sailing | Star Cruises cancelled a scheduled sailing from Hong Kong due to an unforeseen technical issue, leaving passengers frust | [Link](https://longbridge.com/en/news/275957717.md) |
| Meitu Sees 2025 Net Profit Between 60-66% Y/Y By IFRS | Meitu Inc :SEES 2025 NET PROFIT BETWEEN 60-66% Y/Y BY IFRS | [Link](https://longbridge.com/en/news/275224699.md) |
| Everest Medicines erhält Zulassung für VELSIPITY in China | Everest Medicines Ltd. has received approval from the National Medical Products Administration (NMPA) in China for VELSI | [Link](https://longbridge.com/en/news/275069370.md) |
| Hengrui Pharma Gets Nod for Solid Tumor Injection's Clinical Trials | Hengrui Pharma Gets Nod for Solid Tumor Injection's Clinical Trials | [Link](https://longbridge.com/en/news/273791098.md) |
| Is Now The Time To Look At Buying Meitu, Inc. (HKG:1357)? | Meitu, Inc. (HKG:1357) has seen a share price increase of over 10% recently, but it remains below its yearly peak. Analy | [Link](https://longbridge.com/en/news/274087132.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.